Hilvo et al. performed a lipidomic analysis in patients with established coronary heart disease after administration of a RG7652, a fully human PCSK9 monoclonal antibody, to characterize the lipidome alterations of plasma and major lipoprotein particles (67). The gene discussed is PCSK9; the disease is coronary artery disorder.